Premium Portfolio of Stem Cell Research Related Domain Names Going on the Auction Block
This premium portfolio of Stem Cell research related domain names includes: Thirty two Domain names for Amniotic Stem Cell research, seven Domain names for Skin Stem Cell research and two Domain names for Germ Stem Cell research.
Long Beach, CA (PRWEB) June 18, 2007 -- In the coming months and years, it is projected that each of these Stem Cells research area's will be three of the top ways in which scientist and bio tech research companies will harvest stem cells. These new techniques will soon eliminate the need to use human eggs or embryos to make cells that are, for all intents and purposes, human embryonic stem cells.
Amniotic Stem Cells:
As stem-cell researcher Malcolm Alison of the University of London told the Daily Mail, the "amniotic cells appear to be at least as malleable as embryonic stem cells but without all the ethical baggage."
Amniotic stem cells may be the most easily differentiated of all--as well as among the easiest to extract in large amounts. Indeed, they are routinely recovered with a hypodermic needle during amniocentesis. While it's widely believed that this procedure slightly increases the chance of miscarriage, a sizable study last November of 35,000 women who underwent mid-trimester testing found no significant difference in loss rates between those undergoing amniocentesis and those not undergoing amniocentesis.
There are over four million births each year in the United States, yet Atala calculates that merely 100,000 amniotic stem cell specimens could supply 99 percent of the U.S. population's needs for perfect matches for transplants. (That assumes a perfect match is even needed.) About 700,000 amniocentesis procedures are performed in the United States and Western Europe each year.
Life News Article
Skin Stem Cells:
Last week Congress passed, for the third time, an attempt to water down the president's pro-life stance on embryonic stem-cell research. President Bush has promised a veto of the legislation. Also last week, researchers discovered that skin cells can be converted into embryonic-like cells without destroying a life. Coincidence? Similar breakthroughs were discovered around the same time as each vote by Congress.
Before the House vote on HR 3 in January, scientists published evidence that a type of adult stem cell -- amniotic fluid cells -- were just as flexible as embryonic stem cells. A treatment for diabetes using adult stem cells was heralded as a medical breakthrough the same week in April that the Senate voted on identical legislation (S. 5). And just last week, a new study showed that adult cells can be converted to embryonic-like stem cells without destroying embryos.
Wasington Post Article
Germ Stem Cells:
The newest frontier, researcher's are currently working on developing beneficial stem cells from germ cells.
Geneng News
The Vision:
This premium Stem Cell research domain portfolio will allow the new owner(s) a wide variety of options to attract investors to their projects, post research data, and give your company or research program instant credibility with a solid presents on the Internet by using these premium domain names for marketing and internet traffic generation. Additional, the value of these premium domain names will only increase in value in the coming months and years.
One Final Thought:
The new owner(s) of these domains will not only have some of the most highly sought after premium domain names in the billion dollar Stem Cell industry, but at the same time will deny his or her competition access to these same valuable assets. This will prove to be a huge advantage over your competitors in the coming months and years.
Domain Portfolio Auction Now On Ebay ~ Please Click Here
http://iptvdomains.com/
Still For Sale: Contact Dan At: jv @ iptvdomains.com
# # #
Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/TG92ZS1Qcm9mLVNxdWEtQ291cC1UaGlyLVplcm8=
Bookmark -
Del.icio.us |
Digg |
Furl It |
Spurl |
RawSugar |
Simpy |
Shadows |
Blink It |
My Web
|
Share The News
Submit this press release easily to any of these major bookmarking and social media sites.